Given the association of TEX with better response to therapy in autoimmune disease (12, 13, 15), we explored the relationship between TIGIT+KLRG1+ TEX frequency and HLA risk alleles in the setting of immune interventions leveraging recent clinical trials. This evidence concerns the gene TEX46 and autoimmune disease.